Health Care/Hospital

Announcement of The Shaw Laureates 2025

HONG KONG, May 27, 2025 /PRNewswire/ --  The Shaw Laureates 2025 (from left to right): John Richard Bond and George Efstathiou, The Shaw Prize in Astronomy; Wolfgang Ba...

2025-05-27 19:36 5105

United Imaging and HKSH Medical Group Establish Strategic Partnership to Elevate Imaging Excellence

HONG KONG, May 27, 2025 /PRNewswire/ -- United Imaging and HKSH Medical Group announced on Monday the signing of a Memorandum of Understanding (MOU), marking a significant step forward in fostering innovation and shared commitment. The signing ceremony was held during the Asia Summit Global Healt...

2025-05-27 19:15 2308

RemeGen: Telitacicept for the Treatment of Generalized Myasthenia Gravis Approved in China

YANTAI, China, May 27, 2025 /PRNewswire/ -- On May 27, RemeGen Co., Ltd.(688331.SH / 09995.HK) announced that Telitacicept has officially been approved for marketing in China by the National Medical Products Administration (NMPA) for the treatment of adult patients with anti-acetylcholine recepto...

2025-05-27 16:30 2725

Alma Unveils Alma IQ at Eighth Global Alma Academy in Dubrovnik

The next-generation skin analysis platform, set to redefine the aesthetic consultation experience CAESAREA, Israel, May 27, 2025 /PRNewswire/ -- Alma , a Sisram Medical company and a global leader in energy-based medical and aesthetic solutions, has officially launchedA...

2025-05-27 07:00 2552

May 19: World Inflammatory Bowel Disease Day | Healthy Gut, Happy Life

SHENZHEN, China, May 26, 2025 /PRNewswire/ -- May 19 is designated as World Inflammatory Bowel Disease (IBD) Day, aimed at raising public awareness of IBD patients and improving their quality of life and medical care. The European Federation of Crohn's and Ulcerative Colitis Associations (EFCCA),...

2025-05-26 21:24 4273

Neutech Group strategically expands wellness tourism business resources, accelerating the development of new ecosystem of education, healthcare, wellness and mind tour

HONG KONG, May 26, 2025 /PRNewswire/ -- On 20 May 2025, Neutech Group Limited ("Neutech Group" or the "Group"; stock code: 9616.HK) announced the acquisition of partial equity interest in Xikang Wellness & Resorts, which will further strengthen the Group's integration of resources in the "wellnes...

2025-05-26 18:26 6439

Esaote: The new MyLab™Heron ultrasound scanner for veterinary physicians had its world premiere at the SCIVAC Rimini 2025 Congress

GENOA, Italy, May 26, 2025 /PRNewswire/ -- Esaote, a leading company in the field of medical diagnostic imaging, has presented the world premiere of the new MyLab™Heronultrasound system at the Congress organized in Rimini from May 23 to 25 Mayby SCIVAC, the largest Veterinary Scientific Society in...

2025-05-26 18:00 2946

Abbisko Therapeutics Receives CDE Approval of Breakthrough Therapy Designation for Irpagratinib (ABSK011) in the Treatment of HCC

SHANGHAI, May 26, 2025 /PRNewswire/ -- Abbisko Therapeutics (HKEX Code: 02256) announced that its self-developed, highly selective small molecule FGFR4 inhibitor, irpagratinib (ABSK011), has received approval of Breakthrough Therapy Designation from the Center for Drug Evaluation (CDE) of the Chi...

2025-05-26 12:15 6682

Phase 3 Clinical Study of Mazdutide in Chinese Adults with Overweight or Obesity (GLORY-1) Published in The New England Journal of Medicine (NEJM)

SAN FRANCISCO and SUZHOU, China, May 26, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncologic, autoimmune, cardiovascular and metabolic...

2025-05-26 08:00 4528

EDAN Highlights Commitment to Global Health at GHF 2025 Satellite Symposium, a Side Event of the World Health Assembly

GENEVA, May 25, 2025 /PRNewswire/ -- Edan Instruments, Inc. (300206.SZ), a leading global medical device company, participated in the Geneva Health Forum (GHF) 2025 Satellite Symposium, held as a side event of the World Health Assembly (WHA). Titled "China's Medical Techno...

2025-05-25 21:41 5510

Mindray Debuts Next-Generation BeneVision V Series Patient Monitoring System at Euroanaesthesia 2025

SHENZHEN, China, May 25, 2025 /PRNewswire/ -- Mindray  (SZSE: 300760), a leading global developer of healthcare technologies, launched itsBeneVision V Series patient monitoring solution at Euroanaesthesia 2025 in Lisbon. Powered by a robust new hardware platform, this ad...

2025-05-25 19:00 4229

Menarini Group Presents Updated Data Underscoring the Combinability of Elacestrant (ORSERDU®) in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the ASCO 2025 Annual Meeting

* Preliminary efficacy analysis from the elacestrant plus everolimus and ribociclib cohorts of the ELEVATE study, along with updated safety data from additional cohorts of elacestrant plus targeted therapy combination arms, will be presented. * These data highlight elacestrant's potential ro...

2025-05-23 18:07 4904

Six Abstracts of Kelun-Biotech's Clinical Studies Published at the 2025 ASCO Annual Meeting

CHENGDU, China, May 23, 2025 /PRNewswire/ -- The 2025 American Society of Clinical Oncology (ASCO) Annual Meeting is scheduled to take place in Chicago, Illinois, USA from May 30 to June 3. Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (6990.HK, the "Company") will present results from six cl...

2025-05-23 17:24 5410

England's NICE recommends FILSPARI® (sparsentan) as a treatment option for IgA nephropathy

First non-immunosuppressive dual-action therapy recommended by NICE for eligible patients with IgA nephropathy, a leading cause of kidney failure1-3 NICE's recommendation is based on clinically meaningful results from the phase-III PROTECT trial4 ST. GALLEN, Switzerland, May 23, 2025 /PRNewswi...

2025-05-23 16:16 4936

Sporting Goods Industry Unites: Urgent Action Needed to Tackle Physical Inactivity Crisis Projected to Cost $300B by 2030

* The global sporting goods industry launched the first-ever Sporting Goods Physical Activity Impact Report: Moving the World Toward an Active Future at an exclusive World Health As...

2025-05-23 16:00 3398

ADVANCING ENDOSCOPIC EXCELLENCE

Pantai Hospital Kuala Lumpur Reaches 50 POEM Cases, Leading the Way in Minimally Invasive, Incisionless Treatment KUALA LUMPUR, Malaysia, May 23, 2025 /PRNewswire/ -- Pantai Hospital Kuala Lumpur (PHKL) proudly celebrates a major milestone in its endoscopic journey, having successfully performe...

2025-05-23 14:28 2506

Antengene to Present Latest Clinical Results from Two Studies in CPI-resistant Solid Tumors at ASCO 2025

* ATG-037, an oral small molecule CD73 inhibitor, in combination with MSD's anti-PD-1 therapy, KEYTRUDA® (pembrolizumab), achieved an overall response rate (ORR) of 36.4% and disease control rate (DCR) of 100% in checkpoint inhibitor (CPI)-resistant melanoma patients in the ongoing STAMINA-01 t...

2025-05-23 12:31 5251

Everest Medicines Announces NEFECON® Inclusion in China's Clinical Practice Guideline for IgA Nephropathy and IgA Vasculitis in Chinese Adults (For Public Review)

SHANGHAI, May 23, 2025 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics,announced that NEFECON® has been included in the "Clin...

2025-05-23 11:39 3313

MindHYVE.ai™ and Islamabad Diagnostic Centre Forge Strategic Alliance to Launch AGI-Powered Diagnostic Intelligence Across Pakistan

ISLAMABAD, May 23, 2025 /PRNewswire/ -- In a groundbreaking move to elevate clinical diagnostics nationwide, MindHYVE.ai™, a U.S.-based pioneer in orchestrated agentic AI and swarm-intelligent systems, has signed a formal Memorandum of Understanding (MoU) with Islamabad Diagnostic Centre (IDC). T...

2025-05-23 09:18 2799

Great Novel Therapeutics Biotech & Medicals Corporation (GNTbm) Presented Preclinical Data on GNTbm-38, an Novel Epigenetic Immune Activator, at the 2025 ASCO Annual Meeting

TAIPEI, May 23, 2025 /PRNewswire/ -- GNTbm (stock code: 7427, Taiwan) announced the preclinical data on GNTbm-38, an novel epigenetic immune activator for cancer immunotherapy. GNTbm-38 was presented as posters at the 2025 American Association of Clinical Oncology (ASCO) Annual Meeting, which ...

2025-05-23 08:00 3018
1 ... 106107108109110111112 ... 540